Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Migraine without Aura D020326 1 associated lipids
Mouth, Edentulous D009066 1 associated lipids
Anthrax D000881 1 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Leukostasis D018921 1 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Pulmonary Atelectasis D001261 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Leukocyte-Adhesion Deficiency Syndrome D018370 1 associated lipids
Dictyocaulus Infections D004022 1 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Hemorrhagic Fever, American D006478 2 associated lipids
Bovine Virus Diarrhea-Mucosal Disease D001912 2 associated lipids
Ileitis D007079 2 associated lipids
Jaundice, Obstructive D041781 2 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Multiple Trauma D009104 2 associated lipids
Amnesia, Anterograde D020324 2 associated lipids
Soft Tissue Injuries D017695 2 associated lipids
Dementia, Multi-Infarct D015161 2 associated lipids
Capillary Leak Syndrome D019559 2 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Ileal Diseases D007077 3 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Extravasation of Diagnostic and Therapeutic Materials D005119 3 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Dyslexia D004410 3 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Hematoma, Subdural D006408 3 associated lipids
Contracture D003286 3 associated lipids
Toxemia D014115 3 associated lipids
Bronchial Diseases D001982 3 associated lipids
Pneumonia, Pneumococcal D011018 3 associated lipids
Bronchopulmonary Sequestration D001998 3 associated lipids
Hypertrophy, Right Ventricular D017380 4 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Thrombasthenia D013915 4 associated lipids
Thrombocytosis D013922 4 associated lipids
Cluster Headache D003027 4 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Bronchopulmonary Dysplasia D001997 4 associated lipids
Viremia D014766 4 associated lipids
Brain Injuries D001930 4 associated lipids
Neoplasms, Germ Cell and Embryonal D009373 4 associated lipids
Burns, Inhalation D002059 4 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Shock, Traumatic D012774 4 associated lipids
Asphyxia Neonatorum D001238 4 associated lipids
Spasm D013035 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Strongylida Infections D017206 5 associated lipids
Liver Failure D017093 5 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Colonic Diseases D003108 5 associated lipids
Shock, Cardiogenic D012770 5 associated lipids
Sneezing D012912 6 associated lipids
Thrombophilia D019851 6 associated lipids
Gliosis D005911 6 associated lipids
Heart Injuries D006335 6 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Coronary Stenosis D023921 6 associated lipids
Xeroderma Pigmentosum D014983 6 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Mucositis D052016 7 associated lipids
Bronchiectasis D001987 7 associated lipids
Agranulocytosis D000380 7 associated lipids
Pneumococcal Infections D011008 7 associated lipids
Rheumatic Diseases D012216 7 associated lipids
Coronary Thrombosis D003328 7 associated lipids
Ear Diseases D004427 7 associated lipids
Pelvic Pain D017699 7 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Rhinitis, Allergic, Seasonal D006255 7 associated lipids
Klebsiella Infections D007710 7 associated lipids
Glomerulonephritis, IGA D005922 7 associated lipids
Conjunctivitis D003231 7 associated lipids
Disseminated Intravascular Coagulation D004211 7 associated lipids
Behcet Syndrome D001528 7 associated lipids
Infant, Premature, Diseases D007235 7 associated lipids
Arteriosclerosis Obliterans D001162 8 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Thalassemia D013789 8 associated lipids
Cholecystitis D002764 8 associated lipids
Arthus Reaction D001183 8 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Corneal Neovascularization D016510 8 associated lipids
Lupus Nephritis D008181 8 associated lipids
Aggressive Periodontitis D010520 8 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Tselepis AD et al. Electrocardiographic alterations induced by AGEPC in Wistar rats in relation to its hypotensive and hematologic effects. 1987 Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol. pmid:2885139
Hayashi M et al. Characterization of the activity of a platelet activating factor antagonist, CV-3988. 1987 Jpn. J. Pharmacol. pmid:2888915
Bussolino F et al. Chick retina generates platelet-activating factor. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2890284
Mikashima H et al. An antagonistic activity of etizolam on platelet-activating factor (PAF). In vitro effects on platelet aggregation and PAF receptor binding. 1987 Jpn. J. Pharmacol. pmid:2890779
McFall TL et al. Effect of group B streptococcal type-specific antigen on polymorphonuclear leukocyte function and polymorphonuclear leukocyte-endothelial cell interaction. 1987 Pediatr. Res. pmid:3037472
Ingraham LM et al. In vitro and in vivo effects of treatment by platelet-activating factor on N-formyl-met-leu-phe-mediated responses of polymorphonuclear leucocytes. 1987 Br. J. Haematol. pmid:3038160
Criscuoli M and Subissi A Paf-acether-induced death in mice: involvement of arachidonate metabolites and beta-adrenoceptors. 1987 Br. J. Pharmacol. pmid:2880624
Englberger W et al. Influence of lysophospholipids and PAF on the oxidative burst of PMNL. 1987 Int. J. Immunopharmacol. pmid:3038761
Doly M et al. Effects of platelet-activating factor on electrophysiology of isolated retinas and their inhibition by BN 52021, a specific PAF-acether receptor antagonist. 1987 Immunopharmacology pmid:3038784
Montrucchio G et al. In vitro oxytocic activity of platelet-activating factor on human myometrium. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960158
Homma H et al. Binding and internalization of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in washed rabbit platelets. 1987 J. Biol. Chem. pmid:3038889
Mallet AI et al. Platelet activating factor in chronic plaque psoriasis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960170
Bourgain RH et al. Effect of ginkgolide PAF-acether antagonists on arterial thrombosis. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960196
Braquet P et al. Platelet-activating factor: a potential mediator of shock. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960197
Myers A et al. Pharmacological manipulation of platelet-activating factor toxicity in rodents. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2960198
Rylander R and Beijer L Inhalation of endotoxin stimulates alveolar macrophage production of platelet-activating factor. 1987 Am. Rev. Respir. Dis. pmid:3541718
Dejana E et al. Modulation of endothelial cell functions by different molecular species of interleukin 1. 1987 Blood pmid:3542082
Jancar S et al. Comparative effects of platelet activating factor, leukotriene D4 and histamine on guinea pig trachea, bronchus and lung parenchyma. 1987 Prostaglandins pmid:3588970
Malo PE et al. Enhancement of leukotriene D4-induced contraction of guinea-pig isolated trachea by platelet activating factor. 1987 Prostaglandins pmid:3588971
Joseph R et al. Sensitivity to PAF is increased in migraine patients. 1987 Thromb. Haemost. pmid:3590077
Valone FH Inhibition of platelet-activating factor binding to human platelets by calcium channel blockers. 1987 Thromb. Res. pmid:3590086
Tokumura A et al. Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists. 1987 Thromb. Res. pmid:3590110
Bamford CH et al. Polymeric inhibitors of platelet aggregation. II. Copolymers of dipyridamole and related drugs with N-vinylpyrrolidone. 1987 Biochim. Biophys. Acta pmid:3828396
Christman BW et al. Effect of platelet-activating factor on aerosol histamine responsiveness in awake sheep. 1987 Am. Rev. Respir. Dis. pmid:3592402
Benveniste J A role for paf-acether (platelet-activating factor) in bronchial hyperreactivity? 1987 Am. Rev. Respir. Dis. pmid:3592414
Cox CP and Wood KL Selective antagonism of platelet-activating factor (PAF)-induced aggregation and secretion in washed rabbit platelets by CV-3988, L-652731, triazolam and alprazolam. 1987 Thromb. Res. pmid:3629553
Ostermann G et al. Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor. 1987 Thromb. Res. pmid:3629555
Pettipher ER et al. PAF-acether in chronic arthritis. 1987 Agents Actions pmid:3630862
Stenmark KR et al. Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia. 1987 Am. Rev. Respir. Dis. pmid:3631747
O'Donnell SR and Barnett CJ Microvascular leakage to platelet activating factor in guinea-pig trachea and bronchi. 1987 Eur. J. Pharmacol. pmid:3040440
Hansen JF and Hansen BF [Unstable angina pectoris, acute myocardial infarct, sudden heart death. Patho-anatomy and pathophysiology]. 1987 Ugeskr. Laeg. pmid:3324429
Violi F et al. Human platelet aggregation by PAF and thromboxane production. 1987 Thromb. Res. pmid:3424290
Muirhead EE Vasodepressor lipid of the renomedullary interstitial cells of the renal papilla is a prohormone activated by the liver. 1987 Agents Actions Suppl. pmid:3324720
Mest HJ et al. Relevance of eicosanoids for biochemical regulation of cardiac rhythm disturbances. 1987 Biomed. Biochim. Acta pmid:3325045
Bloom JW et al. Intravenous platelet activating factor does not affect lung epithelial permeability. 1987 Res. Commun. Chem. Pathol. Pharmacol. pmid:3326081
de Almeida PJ et al. [Biochemical bases of platelet activity in homeostasis and thrombogenesis. III]. 1987 Arq. Bras. Cardiol. pmid:3328601
O'Neill C Embryo-derived platelet activating factor: a preimplantation embryo mediator of maternal recognition of pregnancy. 1987 Domest. Anim. Endocrinol. pmid:3333935
Kester M et al. Elevation of cytosolic free calcium by platelet-activating factor in cultured rat mesangial cells. 1987 FASEB J. pmid:2442057
Chabot MC et al. Reacylation of platelet activating factor with eicosapentaenoic acid in fish-oil-enriched monkey neutrophils. 1987 Biochim. Biophys. Acta pmid:2823907
HÃ¥kansson L et al. New method for the measurement of eosinophil migration. 1987 J. Leukoc. Biol. pmid:2445885
Sciberras DG et al. Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E2 in healthy volunteers: a double blind investigation. 1987 Br J Clin Pharmacol pmid:2449904
Czarnetzki BM [Mediators and the bronchial system. Pathophysiologic and biochemical aspects of mediators of the bronchial system]. 1987 Wien Med Wochenschr Suppl pmid:3078398
Schwertschlag U et al. L-platelet activating factor induces changes on renal vascular resistance, vascular reactivity, and renin release in the isolated perfused rat kidney. 1987 Circ. Res. pmid:3297384
Page CP A role for platelet activating factor and platelets in the induction of bronchial hyperreactivity. 1987 Int J Tissue React pmid:3298115
Lian EC Pathogenesis of thrombotic thrombocytopenic purpura. 1987 Semin. Hematol. pmid:3299722
Camussi G et al. Release of platelet-activating factor from rabbit heart perfused in vitro by sera with transplantation alloantibodies. 1987 Transplantation pmid:3299910
Zimmerman GA et al. Production of platelet-activating factor, a biologically active lipid, by vascular endothelial cells. 1987 Am. Rev. Respir. Dis. pmid:3300444
Touvay C et al. Gossypol: a potent inhibitor of PAF-acether- and leukotriene-induced contractions of guinea-pig lung parenchyma strips. 1987 J. Pharm. Pharmacol. pmid:2886603
Sudan BJ Ketoconazole, leukotrienes, Paf-acether and nicotine as a hapten: the possible aetiology of seborrhoeic dermatitis. 1987 Med. Hypotheses pmid:2886895
Ostermann G et al. Modification of the polar head group of platelet-activating factor: influence on the biological activity. 1987 Chem. Phys. Lipids pmid:3607969
Chung KF et al. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man. 1987 Lancet pmid:2880069
Casals-Stenzel J and Weber KH Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity. 1987 Br. J. Pharmacol. pmid:2880622
Gentry PA et al. Inhibitory effect of trichothecene mycotoxins on bovine platelets stimulated by platelet activating factor. 1987 Can. J. Vet. Res. pmid:3453270
Sugatani J et al. Potential involvement of vicinal sulfhydryls in stimulus-induced rabbit platelet activation. 1987 J. Biol. Chem. pmid:2824509
Leff AR et al. Parasympathetic involvement in PAF-induced contraction in canine trachealis in vivo. 1987 J. Appl. Physiol. pmid:2881917
Spinks NR and O'Neill C Embryo-deprived platelet-activating factor is essential for establishment of pregnancy in the mouse. 1987 Lancet pmid:2432367
McIntyre TM et al. Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils. 1987 J. Biol. Chem. pmid:2824456
Feuerstein G and Hallenbeck JM Prostaglandins, leukotrienes, and platelet-activating factor in shock. 1987 Annu. Rev. Pharmacol. Toxicol. pmid:3034139
Khandwala A et al. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release. 1987 Biochem. Pharmacol. pmid:2435293
Bussolino F et al. Human endothelial cells are target for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. 1987 J. Immunol. pmid:3116081
Bitterman H et al. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock. 1987 Methods Find Exp Clin Pharmacol pmid:3116357
Gateau O [Role of PAF-acether (platelet activating factor) in cardio-vascular pathology]. 1987 Arch Mal Coeur Vaiss pmid:3117010
Altin JG et al. Evidence that Ca2+ fluxes and respiratory, glycogenolytic and vasoconstrictive effects induced by the action of platelet-activating factor and L-alpha-lysophosphatidylcholine in the perfused rat liver are mediated by products of the cyclo-oxygenase pathway. 1987 Biochem. J. pmid:3117040
Terashita Z et al. A lethal role of platelet activating factor in anaphylactic shock in mice. 1987 J. Pharmacol. Exp. Ther. pmid:3118009
Sperling RI et al. The effects of N-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes. 1987 J. Immunol. pmid:2826583
de Arriba G et al. Changes in glomerular cross-sectional area induced by platelet activating factor. 1987 Nephrol. Dial. Transplant. pmid:3118261
Darius H and Lefer AM Pharmacologic antagonism of platelet activating factor and peptide leukotrienes inhibits guinea pig anaphylaxis. 1987 Prog. Clin. Biol. Res. pmid:3118384
Musch MW et al. Antigen-and ionophore-stimulated synthesis of platelet-activating factor by the cloned mast cell line, MC9. 1987 Biochem. Biophys. Res. Commun. pmid:3107564
Sisson JH et al. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism. 1987 J. Immunol. pmid:3035016
Michel L et al. Biologic properties of LTB4 and paf-acether in vivo in human skin. 1987 J. Invest. Dermatol. pmid:3035030
Di Marzo V et al. Neuropeptides and leukotriene release: effect of peptide histidine isoleucine and secretin in platelet activating factor-stimulated rat lung. 1987 Neuropeptides pmid:3031537
Liu BN [Neoplastic membrane-toxic activity as one of the pathogenetic factors in blood cell and tumor growth changes]. 1987 Jan-Feb Patol Fiziol Eksp Ter pmid:3550649
Lurie A et al. Exercise- and allergen-induced asthma do not change the production of Paf-acether by neutrophils and platelets. 1987 Jul-Aug Bull Eur Physiopathol Respir pmid:3690021
Auriault C et al. The effector function of platelets is induced and regulated by T lymphocytes. 1987 Jul-Aug Ann. Inst. Pasteur Immunol. pmid:3118905
Fiedler VB et al. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs. 1987 Mar-Apr Basic Res. Cardiol. pmid:3606544
Arnoux B et al. Antigenic release of paf-acether and beta-glucuronidase from alveolar macrophages of asthmatics. 1987 Mar-Apr Bull Eur Physiopathol Respir pmid:3607326
Berdel WE et al. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro. 1987 Nov-Dec Anticancer Res. pmid:3442414
Lakin KM et al. [Action of calcium antagonists on thrombocyte aggregation]. 1987 Sep-Oct Farmakol Toksikol pmid:2826225
Bochner BS et al. Adherence of human basophils to cultured umbilical vein endothelial cells. 1988 J. Clin. Invest. pmid:3130394
Lerner R et al. Platelet activating factor and leukotriene B4 induce hyperpolarization of human endothelial cells but depolarization of neutrophils. 1988 Biochem. Biophys. Res. Commun. pmid:2838025
Kok PT et al. Arachidonic acid can induce leukotriene C4 formation by purified human eosinophils in the absence of other stimuli. 1988 Biochem. Biophys. Res. Commun. pmid:3132917
Lazanas M et al. PAF of biological fluids in disease: IV. Levels in blood in allergic reactions induced by drugs. 1988 Arch. Dermatol. Res. pmid:3395143
Satoh K et al. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease. 1988 Prostaglandins pmid:3399678
Rosario-Jansen T et al. Phospholipids chiral at phosphorus. Synthesis and stereospecificity of phosphorothioate analogues of platelet-activating factor. 1988 Biochemistry pmid:3167004
Prévost MC et al. Possible origins of PAF-acether and lyso-PAF-acether in rat lung alveoli secondary to hypoxia. 1988 Biochim. Biophys. Acta pmid:3167085
Bonventre JV et al. PAF and PDGF increase cytosolic [Ca2+] and phospholipase activity in mesangial cells. 1988 Am. J. Physiol. pmid:3337246
Wallace JL and Whittle BJ Gastrointestinal damage induced by platelet-activating factor. Inhibition by the corticoid, dexamethasone. 1988 Dig. Dis. Sci. pmid:3338370
Benveniste J et al. Preformed PAF-acether and lyso PAF-acether are bound to blood lipoproteins. 1988 FEBS Lett. pmid:3338565
Ma YH and Dunham EW Antagonism of the vasodilator effects of a platelet activating factor precursor in anesthetized spontaneously hypertensive rats. 1988 Eur. J. Pharmacol. pmid:2832188
Hellegouarch A et al. Lack of effect of atrial natriuretic factor on the tone induced in rat portal vein by platelet-activating factor. 1988 Eur. J. Pharmacol. pmid:2832190
Valone FH Identification of platelet-activating factor receptors in P388D1 murine macrophages. 1988 J. Immunol. pmid:2832476
Kimani G et al. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor. 1988 J. Immunol. pmid:3361129
Robertson DA et al. Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity. 1988 J. Pharmacol. Exp. Ther. pmid:3361438
Terashita Z et al. Protective action of prostaglandin E1 (PGE1) against constrictor mediators in isolated rat heart and lung. 1988 Biochem. Pharmacol. pmid:2839198
Prpic V et al. Biochemical and functional responses stimulated by platelet-activating factor in murine peritoneal macrophages. 1988 J. Cell Biol. pmid:2839520
Plante GE et al. Platelet activating factor antagonism with BN52021 protects the kidney against acute ischemic injury. 1988 Prostaglandins Leukot. Essent. Fatty Acids pmid:3231663
Stephens LR et al. Synthesis of myo-inositol 1,3,4,5,6-pentakisphosphate from inositol phosphates generated by receptor activation. 1988 Biochem. J. pmid:2845930
Santos JC et al. Effect of intrarenal infusion of synthetic PAF-acether in dogs. 1988 Rev. Esp. Fisiol. pmid:3231880
Ukena D and Sybrecht GW [Function of platelet activating factor in asthma]. 1988 Dtsch. Med. Wochenschr. pmid:2846251
Ng DS and Wong K Effect of sulfhydryl reagents on PAF binding to human neutrophils and platelets. 1988 Eur. J. Pharmacol. pmid:2846326